Drug Type Herbal medicine |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anxiety Disorders | Phase 2 | US | 01 Mar 2021 | |
Arthritis, Reactive | Phase 2 | US | 01 Mar 2021 | |
COVID-19 | Phase 2 | US | 01 Mar 2021 | |
Depressive Disorder | Phase 2 | US | 01 Mar 2021 | |
Encephalomyelitis, Acute Disseminated | Phase 2 | US | 01 Mar 2021 | |
Gastroesophageal Reflux | Phase 2 | US | 01 Mar 2021 | |
Osteoarthritis | Phase 2 | US | 01 Mar 2021 | |
Parkinson Disease, Postencephalitic | Phase 2 | US | 01 Mar 2021 | |
Peripheral neuralgia | Phase 2 | US | 01 Mar 2021 | |
Sleep Initiation and Maintenance Disorders | Phase 2 | US | 01 Mar 2021 |